Pralsetinib
About
Therapy type: Targeted therapy
Therapy strategy: RET inhibition
Mappings
NCI Thesaurus: Pralsetinib (ncit:C132295)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| EMA (1) FDA (1) | v::RET | Non-Small Cell Lung Cancer | Pralsetinib | |
| FDA (1) | v::RET | Papillary Thyroid Cancer | Pralsetinib |